From 2013 to 2023, the Blood Grouping Reagents Market in Lithuania showed a gradual decline in value per capita, from $0.55 to $0.48, reflecting a 12.7% decrease over a decade. In recent years, the year-on-year variation was a negative 2% from 2022 to 2023 and a 0% change from 2021 to 2022. Over the last five years, the compound annual growth rate (CAGR) was approximately -0.8%, indicating a steady decline.
In the future, watch for:
- Potential innovations in diagnostic technologies.
- Shifts in healthcare policies affecting demand.
- Economic factors impacting healthcare budgets.
| # | 13 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Spain | 2.14 | 2023 | View data | ||
| 2 | 2 United Kingdom | 1.64 | 2023 | View data | ||
| 3 | 3 Italy | 1.52 | 2023 | View data | ||
| 4 | 4 Greece | 1.35 | 2023 | View data | ||
| 5 | 5 Croatia | 1.01 | 2023 | View data | ||
| 8 | 8 Belgium | 0.65 | 2023 | View data | ||
| 9 | 9 Poland | 0.59 | 2023 | View data | ||
| 10 | 10 Lithuania | 0.48 | 2023 | |||
| 11 | 11 Australia | 0.36 | 2023 | View data | ||
| 12 | 12 Thailand | 0.3 | 2023 | View data | ||
